Overview A Study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH) Status: Completed Trial end date: 2017-06-19 Target enrollment: Participant gender: Summary The purpose of this study is to determine whether BMS-986036 is effective in the treatment of subjects with Non-alcoholic Steatohepatitis (NASH). Phase: Phase 2 Details Lead Sponsor: Bristol-Myers Squibb